Prelude Capital Management, LLC Merrimack Pharmaceuticals Inc Transaction History

Prelude Capital Management, LLC

$1.39 Billion
Q2 2024

Shares

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2020 Feb 16, 2021	SELL	$3.69 - $8.31 $9,963 - $22,437	-2,700 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$3.1 - $4.3 $310 - $430	-100 Reduced 3.57%	2,700 $11,000
Q2 2020 Aug 14, 2020	BUY	$2.21 - $3.88 $6,188 - $10,864	2,800 New	2,800 $9,000
Q1 2020 May 15, 2020	SELL	$1.63 - $3.58 $10,919 - $23,982	-6,699 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$3.15 - $4.67 $20,333 - $30,144	-6,455 Reduced 49.07%	6,699 $21,000
Q3 2019 Nov 14, 2019	BUY	$4.16 - $6.05 $14,784 - $21,501	3,554 Added 37.02%	13,154 $59,000
Q2 2019 Aug 14, 2019	BUY	$4.39 - $5.66 $20,194 - $26,036	4,600 Added 92.0%	9,600 $58,000
Q1 2019 May 15, 2019	BUY	$3.19 - $5.73 $15,950 - $28,650	5,000 New	5,000 $35,000
Q2 2018 Aug 14, 2018	SELL	$3.86 - $7.61 $17,756 - $35,006	-4,600 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$6.24 - $9.15 $28,704 - $42,090	4,600 New	4,600 $37,000

Others Institutions Holding MACK

# of Institutions

12

Shares Held

437K

Call Options Held

0

Put Options Held

0

About MERRIMACK PHARMACEUTICALS INC

Ticker MACK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,410,200
Market Cap $203M
Description
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

More about MACK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.